Drug profile · INN
elagolix, estradiol and norethindrone acetate and elagolix
SHEUR
elagolix, estradiol and norethindrone acetate and elagolix (SHEUR) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Current US regulatory status: approved.
Drug details — elagolix, estradiol and norethindrone acetate and elagolix
- US status
- approved
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
elagolix, estradiol and norethindrone acetate and elagolix (SHEUR) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is elagolix, estradiol and norethindrone acetate and elagolix?
elagolix, estradiol and norethindrone acetate and elagolix (SHEUR) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Current US regulatory status: approved.
What is the brand name for elagolix, estradiol and norethindrone acetate and elagolix?
SHEUR is a marketed brand name for elagolix, estradiol and norethindrone acetate and elagolix. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of elagolix, estradiol and norethindrone acetate and elagolix?
elagolix, estradiol and norethindrone acetate and elagolix has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.